JAMIA OpenBioinformaticsPeer-reviewed journal article
Illustrating Potential Effects of Alternate Control Populations on Real-World Evidence-based Statistical Analyses
Yidi HuangiD, William YuaniD, Isaac S. KohaneiD, Brett K. Beaulieu‐JonesiD
Abstract
Case-control study designs are commonly used in retrospective analyses of Real-World Evidence (RWE). Due to the increasingly wide availability of RWE, it can be difficult to determine whether findings are robust or the result of testing multiple hypotheses. We investigate the potential effects of modifying cohort definitions in a case-control association study between depression and Type 2 Diabetes Mellitus (T2D). We found that small permutations to the criteria used to define the control population result in significant shifts in both the demographic structure of the identified cohort as well as the odds ratio of association. These differences remain present when testing against age and sex-matched controls. We believe this offers strong support for the need for robust guidelines, best practices and regulations around the use of observational RWE for clinical or regulatory decision making.
- organism: human
- assay: electronic health records
- research focus: benchmarking
- approach: statistical model
- Citations
- 4
- FWCI
- 0.37
- Field percentile
- top 41%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leveraging Hardy-Weinberg disequilibrium for association testing in case-control studies
Lin Zhang, Lisa J. Strug, Lei Sun·The Annals of Applied StatisticsPeer-reviewed·May 1, 2023
- Hypothesis Tests for Neyman’s Bias in Case-Control Studies
David Swanson, Rebecca Betensky, Chris Anderson·bioRxiv·Jul 31, 2016
- Mathematical bounds on r2 and the effect size in case-control genome-wide association studies
Sanjana M. Paye, Michael D. Edge·bioRxiv·Dec 17, 2024
- Real-world data from the Japanese National Health Insurance System enable fine phenotyping in a 14K-scale population-based study
Yayoi Otsuka‐Yamasaki, Naoyuki Nishiya, … Atsushi Shimizu·medRxiv·Oct 6, 2025
- Sampling bias in large healthcare claims databases
Alex Dahlen, Vivek Charu·bioRxiv·Oct 3, 2022
- A platform for case-control matching enables association studies without genotype sharing
Mykyta Artomov, Alexander A. Loboda, … Mark J. Daly·bioRxiv·Nov 14, 2018